Tm Bioscience inks first European deal for ID-Tag respiratory viral panel:
This article was originally published in Clinica
Executive Summary
Canadian diagnostics developer Tm Bioscience has signed its first European distribution agreement for its ID-Tag respiratory viral panel (RVP), having appointed Sanbio as exclusive distributor of the product in the Netherlands. The test detects and distinguishes between 20 respiratory viruses, including those associated with avian flu and SARS. The agreement is the first among many that will follow over the next few months, as the company anticipates receiving EU regulatory clearance for the product this year, said Toronto, Ontario-based Tm.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.